These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 30635966)

  • 1. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.
    Hu C; Zhao L; Duan J; Li L
    J Cell Mol Med; 2019 Mar; 23(3):1657-1670. PubMed ID: 30635966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.
    Kim MD; Kim SS; Cha HY; Jang SH; Chang DY; Kim W; Suh-Kim H; Lee JH
    Exp Mol Med; 2014 Aug; 46(8):e110. PubMed ID: 25145391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis.
    Liu P; Qian Y; Liu X; Zhu X; Zhang X; Lv Y; Xiang J
    Front Immunol; 2022; 13():1096402. PubMed ID: 36685534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives.
    Fiore EJ; Mazzolini G; Aquino JB
    Stem Cell Rev Rep; 2015 Aug; 11(4):586-97. PubMed ID: 25820543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.
    Guo Y; Chen B; Chen LJ; Zhang CF; Xiang C
    J Zhejiang Univ Sci B; 2016 Nov.; 17(11):831-841. PubMed ID: 27819130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
    Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
    J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
    Hu C; Wu Z; Li L
    J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies.
    Nazarie Ignat SR; Gharbia S; Hermenean A; Dinescu S; Costache M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice.
    Watanabe Y; Tsuchiya A; Seino S; Kawata Y; Kojima Y; Ikarashi S; Starkey Lewis PJ; Lu WY; Kikuta J; Kawai H; Yamagiwa S; Forbes SJ; Ishii M; Terai S
    Stem Cells Transl Med; 2019 Mar; 8(3):271-284. PubMed ID: 30394698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK; Sayyed HG; Osama A; Sabry D
    Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers.
    van der Helm D; Barnhoorn MC; de Jonge-Muller ESM; Molendijk I; Hawinkels LJAC; Coenraad MJ; van Hoek B; Verspaget HW
    J Cell Mol Med; 2019 Sep; 23(9):6238-6250. PubMed ID: 31245923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models.
    Kamel MM; Baz HGE; Demerdash Z; Hassan S; Salah F; Mansour WA; Hammam O; Atta S; Bayoumi A; Hassan M; Mahmoud S
    Adv Clin Exp Med; 2018 Oct; 27(10):1329-1339. PubMed ID: 30048056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease.
    Yuan M; Hu X; Yao L; Jiang Y; Li L
    Stem Cell Res Ther; 2022 May; 13(1):179. PubMed ID: 35505419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.
    Nasir GA; Mohsin S; Khan M; Shams S; Ali G; Khan SN; Riazuddin S
    J Transl Med; 2013 Mar; 11():78. PubMed ID: 23531302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of adipose tissue stem cells over CD34
    De Luna-Saldivar MM; Marino-Martinez IA; Franco-Molina MA; Rivera-Morales LG; Alarcón-Galván G; Cordero-Pérez P; Rojas-Martínez A; Rodríguez-Padilla C; Muñoz-Espinosa LE
    Ann Hepatol; 2019; 18(4):620-626. PubMed ID: 31147180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice.
    Yamaza T; Alatas FS; Yuniartha R; Yamaza H; Fujiyoshi JK; Yanagi Y; Yoshimaru K; Hayashida M; Matsuura T; Aijima R; Ihara K; Ohga S; Shi S; Nonaka K; Taguchi T
    Stem Cell Res Ther; 2015 Sep; 6(1):171. PubMed ID: 26358689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury.
    Li Q; Zhou X; Shi Y; Li J; Zheng L; Cui L; Zhang J; Wang L; Han Z; Han Y; Fan D
    PLoS One; 2013; 8(4):e62363. PubMed ID: 23638052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis.
    Ren H; Zhao Q; Cheng T; Lu S; Chen Z; Meng L; Zhu X; Yang S; Xing W; Xiao Y; Ren Q; Chi Y; Gu D; Yang R; Han ZC
    Cytotherapy; 2010 May; 12(3):371-83. PubMed ID: 20184502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway.
    Bi H; Ming L; Cheng R; Luo H; Zhang Y; Jin Y
    J Tissue Eng Regen Med; 2017 Oct; 11(10):2685-2698. PubMed ID: 27430962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model.
    Wang X; Wang H; Lu J; Feng Z; Liu Z; Song H; Wang H; Zhou Y; Xu J
    Tissue Eng Regen Med; 2020 Oct; 17(5):683-693. PubMed ID: 32621283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.